220 related articles for article (PubMed ID: 36179244)
21. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
22. Colocalization of Wnt/β-Catenin and ACTH Signaling Pathways and Paracrine Regulation in Aldosterone-producing Adenoma.
De Sousa K; Abdellatif AB; Giscos-Douriez I; Meatchi T; Amar L; Fernandes-Rosa FL; Boulkroun S; Zennaro MC
J Clin Endocrinol Metab; 2022 Jan; 107(2):419-434. PubMed ID: 34570225
[TBL] [Abstract][Full Text] [Related]
23. KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
Kitamoto T; Omura M; Suematsu S; Saito J; Nishikawa T
J Hypertens; 2018 Mar; 36(3):619-627. PubMed ID: 29016532
[TBL] [Abstract][Full Text] [Related]
24. Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.
Kamilaris CDC; Stratakis CA; Hannah-Shmouni F
Front Endocrinol (Lausanne); 2021; 12():632543. PubMed ID: 33776926
[TBL] [Abstract][Full Text] [Related]
25. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
[TBL] [Abstract][Full Text] [Related]
26. Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors.
Zwermann O; Beuschlein F; Mora P; Weber G; Allolio B; Reincke M
Eur J Endocrinol; 2000 Jun; 142(6):689-95. PubMed ID: 10822234
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome.
Santana LS; Guimaraes AG; Almeida MQ
Front Endocrinol (Lausanne); 2022; 13():927669. PubMed ID: 35813615
[TBL] [Abstract][Full Text] [Related]
28. Clinical Translationality of
Kitamoto T; Nishikawa T
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012306
[TBL] [Abstract][Full Text] [Related]
29. Is primary aldosteronism a potential risk factor for aortic dissection? A case report and literature review.
Zhang Y; Luo F; Fan P; Meng X; Yang K; Zhou X
BMC Endocr Disord; 2020 Jul; 20(1):115. PubMed ID: 32736558
[TBL] [Abstract][Full Text] [Related]
30. Aldosterone-Producing Adenoma With a Somatic KCNJ5 Mutation Revealing APC-Dependent Familial Adenomatous Polyposis.
Vouillarmet J; Fernandes-Rosa F; Graeppi-Dulac J; Lantelme P; Decaussin-Petrucci M; Thivolet C; Peix JL; Boulkroun S; Clauser E; Zennaro MC
J Clin Endocrinol Metab; 2016 Nov; 101(11):3874-3878. PubMed ID: 27648962
[TBL] [Abstract][Full Text] [Related]
31. GENETICS IN ENDOCRINOLOGY: Impact of race and sex on genetic causes of aldosterone-producing adenomas.
Nanba K; Rainey WE
Eur J Endocrinol; 2021 May; 185(1):R1-R11. PubMed ID: 33900205
[TBL] [Abstract][Full Text] [Related]
32. An update on novel mechanisms of primary aldosteronism.
Zennaro MC; Boulkroun S; Fernandes-Rosa F
J Endocrinol; 2015 Feb; 224(2):R63-77. PubMed ID: 25424518
[TBL] [Abstract][Full Text] [Related]
33. Primary aldosteronism in a patient with an aldosterone-producing adenoma.
Pekarske SL; Herold DA
Clin Chem; 1993 Aug; 39(8):1729-33. PubMed ID: 8353964
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
J Urol; 1995 Jun; 153(6):1775-80. PubMed ID: 7752314
[TBL] [Abstract][Full Text] [Related]
35. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
[TBL] [Abstract][Full Text] [Related]
36. Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling.
Seccia TM; Mantero F; Letizia C; Kuppusamy M; Caroccia B; Barisa M; Cicala MV; Miotto D; Rossi GP
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2307-13. PubMed ID: 23012392
[TBL] [Abstract][Full Text] [Related]
37. 18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status.
Tezuka Y; Yamazaki Y; Kitada M; Morimoto R; Kudo M; Seiji K; Takase K; Kawasaki Y; Mitsuzuka K; Ito A; Nishikawa J; Asai N; Nakamura Y; Gomez-Sanchez CE; Ito S; Dezawa M; Sasano H; Satoh F
Hypertension; 2019 Jun; 73(6):1283-1290. PubMed ID: 31006333
[TBL] [Abstract][Full Text] [Related]
38. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
Monticone S; Hattangady NG; Penton D; Isales CM; Edwards MA; Williams TA; Sterner C; Warth R; Mulatero P; Rainey WE
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1861-5. PubMed ID: 24037882
[TBL] [Abstract][Full Text] [Related]
39. The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma.
Oki K; Gomez-Sanchez CE
Endocr J; 2020 Oct; 67(10):989-995. PubMed ID: 32968034
[TBL] [Abstract][Full Text] [Related]
40. A novel somatic mutation 145-147delETEinsK in KCNJ5 increases aldosterone production.
Zheng FF; Zhu LM; Zhou WL; Zhang Y; Li MY; Zhu YC; Wang JG; Zhu DL; Gao PJ
J Hum Hypertens; 2017 Nov; 31(11):756-759. PubMed ID: 28974779
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]